Annual report pursuant to Section 13 and 15(d)

Note 8 - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.24.1
Note 8 - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Net operating loss carryforwards $ 67,496 $ 54,845
Share-based awards compensation, tax assets 2,624 3,112
Accrued expenses, tax assets 461 216
R&D Credits 644 413
Depreciation and other 479 384
Unrealized foreign currency (377) (359)
Unrealized foreign currency 377 359
Capitalized R&D 1,165 952
Lease liability 0 3,541
Total deferred tax assets 72,492 63,822
Right-of-use asset 0 (3,270)
Total deferred tax liabilities 0 (3,270)
Less: valuation allowance: (72,492) (60,552)
Net deferred tax asset $ 0 $ 0